KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Washington

SB6183 • 2026

HIV antiviral drug coverage

Concerning coverage for HIV antiviral drugs.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Senator Liias, Senator Harris, Senator Bateman, Senator Cleveland, Senator C. Wilson, Senator Dhingra, Senator Hasegawa, Senator Nobles, Senator Pedersen, Senator Saldaña, Senator Stanford, Senator Trudeau, Senator Valdez
Last action
2026-02-10
Official status
S subst for
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

HIV antiviral drug coverage

HIV antiviral drug coverage

What This Bill Does

  • HIV antiviral drug coverage

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-02-10 Senate

    1st substitute bill substituted.

Official Summary Text

HIV antiviral drug coverage

Current Bill Text

Read the full stored bill text 
AN ACT Relating to coverage for HIV antiviral drugs; reenacting 1
and amending RCW 41.05.017; and adding a new section to chapter 48.43 2
RCW. 3
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:4
NEW SECTION. Sec. 1. A new section is added to chapter 48.43 5
RCW to read as follows: 6
(1) For health plans issued or renewed on or after January 1, 7
2027, except as provided in subsection (2) of this section, a health 8
carrier shall provide coverage for all federal food and drug 9
administration approved HIV antiviral drugs without prior 10
authorization, step therapy, or any other utilization management 11
protocols. 12
(2) If the United States food and drug administration has 13
approved one or more therapeutic equivalents of a drug, device, or 14
product for the prevention of HIV, this section does not require a 15
health plan to cover all of the therapeutically equivalent versions 16
without prior authorization, step therapy, or any other utilization 17
management protocols, if at least one therapeutically equivalent 18
version is covered without prior authorization, step therapy, or any 19
other utilization management protocols. 20
S-3914.1
SENATE BILL 6183
State of Washington 69th Legislature 2026 Regular Session
By Senators Liias, Harris, Bateman, Cleveland, C. Wilson, Dhingra,
Hasegawa, Nobles, Pedersen, Saldaña, Stanford, Trudeau, and Valdez
Read first time 01/16/26. Referred to Committee on Health & Long-
Term Care.
p. 1 SB 6183
Sec. 2. RCW 41.05.017 and 2025 c 389 s 3 and 2025 c 171 s 2 are 1
each reenacted and amended to read as follows: 2
Each health plan that provides medical insurance offered under 3
this chapter, including plans created by insuring entities, plans not 4
subject to the provisions of Title 48 RCW, and plans created under 5
RCW 41.05.140, are subject to the provisions of RCW 48.43.500, 6
70.02.045, 48.43.505 through 48.43.535, 48.43.537, 48.43.545, 7
48.43.550, 70.02.110, 70.02.900, 48.43.190, 48.43.083, 48.43.0128, 8
48.43.780, 48.43.435, 48.43.815, 48.200.020 through 48.200.280, 9
48.200.300 through 48.200.320, 48.43.440, 48.43.845, 48.43.732, 10
section 1 of this act, and chapter 48.49 RCW. 11
--- END ---
p. 2 SB 6183